Vaccine requirements for sustained cellular immunity to an intracellular parasitic infection
- 1 December 1998
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 4 (12) , 1409-1415
- https://doi.org/10.1038/4000
Abstract
The humoral immunity induced by many viral and bacterial vaccines mediates protection that is maintained over a long period of time. In contrast, for other intracellular infections (such as with Leishmania major or Mycobacterium tuberculosis) for which cell-mediated immunity is required for protection, the mechanisms for developing durable responses after vaccination have not been well defined. Here we demonstrate that vaccination with plasmid DNA encoding a specific leishmanial antigen is more effective than leishmanial protein plus recombinant IL-12 in eliciting long-term immunity capable of controlling L. major infection. We also show that leishmanial protein plus IL-12 DNA produces an immunity that lasts much longer than does immunity elicited by leishmanial protein plus IL-12 protein, indicating that the persistence of IL-12 may be the essential determinant in maintaining durable cell-mediated immune responses for an intracellular parasitic infection.Keywords
This publication has 33 references indexed in Scilit:
- Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene ImmunizationScience, 1996
- CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania majorImmunity, 1996
- The Regulation of Immunity to Leishmania MajorAnnual Review of Immunology, 1995
- Leishmania major infection in mice primes for specific major histocompatibility complex class I‐restricted CD8+ cytotoxic T cell responsesEuropean Journal of Immunology, 1994
- B7 and interleukin 12 cooperate for proliferation and interferon gamma production by mouse T helper clones that are unresponsive to B7 costimulation.The Journal of Experimental Medicine, 1994
- Leishmania major‐specific CD8+ T cells are inducers and targets of nitric oxide produced by parasitized macrophagesEuropean Journal of Immunology, 1994
- Helper T cells without CD4: control of leishmaniasis in CD4-deficient miceScience, 1993
- Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.The Journal of Experimental Medicine, 1993
- Recombinant interleukin 12 cures mice infected with Leishmania major.The Journal of Experimental Medicine, 1993
- Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cellsInternational Immunology, 1991